Next On Medicare’s To Do List For Alzheimer’s: Coverage Of PET Scans And Genetic Testing

 
• By Cathy Kelly
  
Progress In Covering Diagnostics and Testing also Will Benefit Future Treatments Like Donanemab • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet